Antiviral compounds and method for treating RNA viral infection, particularly COVID-19 Grant US-11696911-B2 United States of America 11 Jul 2023
P38-INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM Application WO-2023280911-A1 World Intellectual Property Organisation (WIPO) 12 Jan 2023
COVID-19 THERAPEUTIC AGENT AND USE OF COMPOUND FOR PRODUCING COVID-19 THERAPEUTIC AGENT Application WO-2022250100-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 Application WO-2022195558-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
USE OF THE AXL INHIBITOR SLC-391 AS ANTIVIRAL THERAPEUTIC AGENT Application WO-2022165436-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2022
RNA INTERACTOME CAPTURING PROTOCOL AND ANTIVIRAL COMPOSITION DISCOVERED USING SAME Application WO-2022092995-A2 World Intellectual Property Organisation (WIPO) 05 May 2022
PEPTIDE FOR TREATING CORONAVIRUS INFECTIONS Application WO-2021239165-A3 World Intellectual Property Organisation (WIPO) 20 Jan 2022
ACTIVATED REPORTER PROTEIN FOR THE DETECTION OF INFECTION IN A BIOLOGICAL SAMPLE Application EP-3932941-A1 European Patent Office 05 Jan 2022
MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE CHECKPOINT FOR TREATING ACUTE… Application WO-2021245107-A2 World Intellectual Property Organisation (WIPO) 09 Dec 2021